Prostate cancer is the most common cancer among American men. But even today, there are still controversies surrounding its screening and treatment.
Our prostate cancer experts will present the latest information about screening and diagnosis and will provide an overview of treatment options. A prostate cancer survivor will also share his story- NYU Cancer Institute
Anna Ferrari, M.D., is Associate Professor for the Department of Medicine in Oncology at NYU Langone Medical Center.
William C. Huang
William C. Huang, M.D., is Associate Professor for the Department of Urology at NYU Langone Medical Center and a member of NYU Urology Associates.
Deborah Koeppel, LCSW, is a Senior Social Worker in the Supportive Services Program at the NYU Clinical Cancer Center.
Nicholas Sanfilippo, M.D., is Associate Professor for the Department of Radiation Oncology at NYU Langone MEdical Center and a member of NYU Radiation Oncology Associates.
Immunotherapy will NEVER be an option in the USA for a whole host of reasons
For one thing, immune function can only be significantly altered by the use of naturally occurring interleukins (etc.)
Since corporations may not patent naturally-occurring chemicals, they will never spend the billions the FDA requires to get it approved!